Apyx Medical Co. (NASDAQ:APYX) Short Interest Update

Apyx Medical Co. (NASDAQ:APYX) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 371,100 shares, a decline of 47.5% from the March 31st total of 706,700 shares. Based on an average trading volume of 154,700 shares, the days-to-cover ratio is presently 2.4 days. Approximately 1.3% of the company’s stock are short sold.

Apyx Medical Trading Down 1.3 %

APYX opened at $1.48 on Friday. The stock has a market capitalization of $51.27 million, a P/E ratio of -2.74 and a beta of 1.09. Apyx Medical has a 12 month low of $1.21 and a 12 month high of $7.97. The firm’s fifty day simple moving average is $1.68 and its 200 day simple moving average is $2.13. The company has a current ratio of 5.52, a quick ratio of 4.74 and a debt-to-equity ratio of 1.23.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings data on Thursday, March 21st. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.06). Apyx Medical had a negative net margin of 35.75% and a negative return on equity of 54.90%. The company had revenue of $14.66 million during the quarter, compared to the consensus estimate of $14.40 million. As a group, research analysts anticipate that Apyx Medical will post -0.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Apyx Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. AIGH Capital Management LLC lifted its position in Apyx Medical by 7.7% during the 4th quarter. AIGH Capital Management LLC now owns 2,040,540 shares of the company’s stock worth $5,346,000 after buying an additional 145,309 shares in the last quarter. Taylor Frigon Capital Management LLC lifted its position in Apyx Medical by 2.9% during the 4th quarter. Taylor Frigon Capital Management LLC now owns 638,965 shares of the company’s stock worth $1,674,000 after buying an additional 17,818 shares in the last quarter. Silverberg Bernstein Capital Management LLC lifted its position in Apyx Medical by 1.2% during the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 621,387 shares of the company’s stock worth $845,000 after buying an additional 7,507 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in Apyx Medical by 44.5% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 608,628 shares of the company’s stock worth $1,595,000 after buying an additional 187,350 shares in the last quarter. Finally, Worth Venture Partners LLC lifted its position in Apyx Medical by 12.0% during the 4th quarter. Worth Venture Partners LLC now owns 518,198 shares of the company’s stock worth $1,358,000 after buying an additional 55,592 shares in the last quarter. 55.33% of the stock is owned by institutional investors.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.